Photo from Fabrice Andre/X
May 19, 2024, 02:10
Key messages by Fabrice Andre at ESMOBreast24 session on ctDNA for clinical decision making
Elisa Agostinetto, Medical Oncologist and Research Physician at Jules Bordet, shared on X: .
“At ESMOBreast24 session on ctDNA for clinical decision making. Two key messages by Fabrice Andre:
- The more the disease advances, the more the genomic profile is complex (and harder to treat!)
- The more the disease is advanced, the rise of resistance clones”
Source: Elisa Agostinetto/X